NVIDIA's China AI Accelerator Shipments Drop 44% Amid Export Curbs; Doctolib Stake and $2B Europe AI Push Revealed
NVDA sits 39% above its 52-week low of $164.27.
Summary
NVIDIA shipped 678,000 AI accelerators to mainland China in H1 2026, a 44% year-over-year decline, holding a 34% market share as U.S. export limits constrained supply. The company also took a minority stake in French health platform Doctolib, supplying hardware and open software for proprietary AI models, though terms were not disclosed. Separately, NVIDIA will unveil a $2 billion AI investment in Europe this week, with details pending. The stock slipped 0.8–1.3% premarket, marking a fourth straight decline after revealing open-standard designs for its Vera Rubin platform. Additional moves include a partnership with LSEG to accelerate tick history processing, a minority stake in AI robotics startup Genesis AI, deployment of Blackwell hardware at Scaleway's Copenhagen site, and a $250M five-year compute commitment to UK AI safety research. The China shipment decline underscores ongoing export headwinds, while the European investment and Doctolib stake signal continued expansion into AI infrastructure and healthcare.
At the time of this announcement, NVDA was trading at $228.97 on NASDAQ in the Technology sector, with a market capitalization of approximately $5.5T. The 52-week trading range was $164.27 to $243.37. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.